CAFERGOT

This brand name is authorized in United States. It is also authorized in Hong Kong SAR China, Spain, Turkey.

Active ingredients

The drug CAFERGOT contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Ergotamine UNII `MRU5XH3B48` - ERGOTAMINE TARTRATE
	Read more about Ergotamine
`2`	Caffeine UNII `3G6A5W338E` - CAFFEINE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CA52	Ergotamine, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CA Ergot alkaloids
Discover more medicines within N02CA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	17558
HK	Department of Health Drug Office	14176
TR	İlaç ve Tıbbi Cihaz Kurumu	8699708011702
US	FDA, National Drug Code	0781-5405

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.